American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …
K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease
F Kanwal, JH Shubrook, LA Adams, K Pfotenhauer… - Gastroenterology, 2021 - Elsevier
Find AGA's NASH Clinical Care Pathway App for iOS and Android mobile devices at nash.
gastro. org. Scan this QR code to be taken directly to the website. Nonalcoholic fatty liver …
gastro. org. Scan this QR code to be taken directly to the website. Nonalcoholic fatty liver …
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis
FE Mózes, JA Lee, EA Selvaraj, ANA Jayaswal… - Gut, 2022 - gut.bmj.com
Objective Liver biopsy is still needed for fibrosis staging in many patients with non-alcoholic
fatty liver disease. The aims of this study were to evaluate the individual diagnostic …
fatty liver disease. The aims of this study were to evaluate the individual diagnostic …
Diagnosis and management of cirrhosis and its complications: a review
Importance Cirrhosis affects approximately 2.2 million adults in the US. From 2010 to 2021,
the annual age-adjusted mortality of cirrhosis increased from 14.9 per 100 000 to 21.9 per …
the annual age-adjusted mortality of cirrhosis increased from 14.9 per 100 000 to 21.9 per …
Impact of non-invasive biomarkers on hepatology practice: past, present and future
Over the last two decades, there have been tremendous advances in the non-invasive
diagnosis and risk stratification of chronic liver diseases (CLDs). Non-invasive approaches …
diagnosis and risk stratification of chronic liver diseases (CLDs). Non-invasive approaches …
[HTML][HTML] Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population
I Graupera, M Thiele, M Serra-Burriel… - Clinical …, 2022 - Elsevier
Background & Aims Fibrosis-4 (FIB-4) and the nonalcoholic fatty liver disease fibrosis score
(NFS) are the 2 most popular noninvasive blood-based serum tests proposed for …
(NFS) are the 2 most popular noninvasive blood-based serum tests proposed for …
AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis
This Practice Guidance from the American Association for the Study of Liver Disease
(AASLD) intends to coalesce best practice recommendations for the identification of portal …
(AASLD) intends to coalesce best practice recommendations for the identification of portal …
Liver cirrhosis
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …
Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events
Background & Aims Previous studies on the prognostic significance of non-invasive liver
fibrosis tests in non-alcoholic fatty liver disease (NAFLD) lack direct comparison to liver …
fibrosis tests in non-alcoholic fatty liver disease (NAFLD) lack direct comparison to liver …